Interim report
Page 1
Є Glenmark LIFE SCIENCES Partnership . Innovation . Passion . UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE , 2021 ( in Millions , unless otherwise stated ) Sr. 30 June'21 Particulars No Unaudited Quarter ended 31 March'21 Audited ( Refer Note 4 ) 30 June'20 Unaudited Year Ended 31 March'21 Audited | Income Revenue from Operations 5,248.97 Other Income 39.86 4,671.63 3.41 3,969.68 Total Income 5,288.83 4,675.04 17.30 3,986.98 18,851.65 8.11 18,859.76 Expenses Cost of Materials Consumed 2,599.21 2,266.22 1,819.20 9,761.98 Changes in Inventories of Finished Goods and ( 5.48 ) ( 341.52 ) ( 64.83 ) ( 707.01 ) Work - in - Progress Employee Benefits Expense 369.42 374.90 315.20 1,491.31 Finance Costs 205.50 211.78 228.15 875.47 Depreciation and Amortisation Expense 89.19 84.26 82.59 333.94 Other Expenses 681.34 673.18 522.12 Total Expenses 3,939.18 3,268.82 2,902.43 2,394.63 14,150.32 = > Profit Before Tax ( I - II ) 1,349.65 1,406.22 1,084.55 4,709.44 IV Tax Expenses Current Tax 322.43 347.44 253.08 1,127.46 Deferred Tax 18.09 Total Tax Expenses 340.52 << Profit for the Period / Year ( III - IV ) 1,009.13 11.94 359.38 1,046.84 20.81 66.17 273.89 1,193.63 810.66 3,515.81 VI Other Comprehensive Income ( OCI ) Items that will not be reclassified to profit or loss benefit obligation ( a ) Re - measurement of the post - employment ( 1.76 ) 2.53 ( 3.19 ) ( 7.03 ) ( b ) Income tax relating to the above 0.44 ( 0.64 ) 0.80 VII Total Other Comprehensive Income / ( Loss ) Total Comprehensive Income for the Period / Year ( V + VI ) ( 1.32 ) 1,007.81 1.89 1,048.73 ( 2.39 ) 808.27 1.77 ( 5.26 ) 3,510.55 VIII Earnings per equity share ( Face Value of 2 / - ) ( Not Annualised for the quarter ) ( a ) Basic ( in ) 9.36 9.71 7.52 32.61 ( b ) Diluted ( in ) 9.36 9.71 7.52 32.61 IX Paid up Equity Share Capital , Equity Shares of * 2 / - each 215.61 19.60 19.60 19.60 X Other Equity excluding Revaluation Reserve 7,507.87 See accompanying notes to the Financial Results SCIENCES GLENMARK LI LIFE LIMITED CHANDIOK WALKER C 3 CHARTERE CO LLPS ACCOUNTANTS Glenmark Life Sciences Limited Corporate Office : 4th Floor , OIA House , 470 , Cardinal Gracious Road , Andheri ( E ) , Mumbai , 400 099 , India . Registered Office : Plot No. 170-172 , Chandramouli Industrial Estate , Mohol Bazarpeth , Solapur - 413 213 , India . T : 91 22 68297979 CIN : U74900PN2011PLC139963 E : complianceofficer@glenmarklifesciences.com W : www.glenmarklifesciences.com